Statement of Principles concerning discoid lupus erythematosus (Reasonable Hypothesis) (No. 126 of 2015)

Administered by Department of Veterans' Affairs

Legislation au F2015L01680 Not in force Legislative Instrument

Legislation content

REPATRIATION MEDICAL AUTHORITY

 

INSTRUMENT NO. 126 of 2015

 

VETERANS’ ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

EXPLANATORY STATEMENT

 

 

  1. The Repatriation Medical Authority (the Authority) has determined, under subsection 196B(2) of the Veterans’ Entitlements Act 1986 (the VEA), Statement of Principles concerning discoid lupus erythematosus (Reasonable Hypothesis) (No. 126 of 2015).
  2. The Authority is of the view that there is sound medical-scientific evidence that indicates that discoid lupus erythematosus and death from discoid lupus erythematosus can be related to particular kinds of service.  The Authority has therefore determined this Statement of Principles concerning discoid lupus erythematosus pursuant to subsection 196B(2) of the VEA.

Purpose and Operation

3.             The Statement of Principles will be applied in determining claims under the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).

4.             The Statement of Principles sets out the factors that must as a minimum exist, and which of those factors must be related to the following kinds of service rendered by a person:

 operational service under the VEA;

 peacekeeping service under the VEA;

 hazardous service under the VEA;

 British nuclear test defence service under the VEA;

 warlike service under the MRCA;

 non-warlike service under the MRCA,

before it can be said that a reasonable hypothesis has been raised connecting discoid lupus erythematosus or death from discoid lupus erythematosus, with the circumstances of that service.  The Statement of Principles has been determined for the purposes of both the VEA and the MRCA.

5.             The Repatriation Commission, Military Rehabilitation and Compensation Commission, Veterans’ Review Board or Administrative Appeals Tribunal cannot accept any claim for pension; or a claim for liability or compensation relating to discoid lupus erythematosus or death from discoid lupus erythematosus that was lodged on or after 1 June 1994 in the case of the VEA, or 1 July 2004 in the case of the MRCA respectively, unless this Statement of Principles upholds that claim (subsection 120A(3) of the VEA or subsection 338(3) of the MRCA).

6.             This new Instrument results from an investigation notified by the Authority in the Government Notices Gazette of 4 November 2014 concerning discoid lupus erythematosus in accordance with section 196G of the VEA.  The investigation involved an examination of the sound medical-scientific evidence available to the Authority.

Consultation

7.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to discoid lupus erythematosus in the Government Notices Gazette of 4 November 2014, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  One submission was received for consideration by the Authority during the investigation.

Human Rights

8.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.  A Statement of Compatibility with Human Rights follows.

Finalisation of Investigation

9.             The determining of this new Instrument finalises the investigation in relation to discoid lupus erythematosus as advertised in the Government Notices Gazette of 4 November 2014.

References

10.         A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA.  Any such request must be made in writing to the Repatriation Medical Authority at the following address:

The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

 


Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Statement of Principles No. 126 of 2015

Kind of Injury, Disease or Death: Discoid lupus erythematosus

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).  Part XIA of the VEA requires the determination of these instruments outlining the factors linking particular kinds of injury, disease or death with service such being determined solely on the available sound medical-scientific evidence.

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have discoid lupus erythematosus;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal; and
  • outlines the factors which the current sound medical-scientific evidence indicates must as a minimum exist, before it can be said that a reasonable hypothesis has been raised, connecting discoid lupus erythematosus with the circumstances of eligible service rendered by a person, as set out in clause 4 of the Explanatory Statement.

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICSECR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICSECR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members;
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD);
  • ensuring that those rights "will be exercised without discrimination of any kind as to race, colour, sex, language, religion, political or other opinion, national or social origin, property, birth or other status" (Art 2, ICESCR).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Repatriation Medical Authority Instrument No. 126 of 2015, concerning discoid lupus erythematosus (Reasonable Hypothesis), was enacted to address the need for clear criteria regarding the connection between discoid lupus erythematosus, its severity, and specific military service conditions. This Instrument was developed under the authority conferred by subsection 196B(2) of the Veterans’ Entitlements Act 1986 (VEA) and applies to claims made under both the VEA and the Military Rehabilitation and Compensation Act 2004 (MRCA). The policy objective of this legislation is to facilitate the assessment and determination of claims by specifying the minimum medical-scientific factors that must exist to establish a reasonable hypothesis linking discoid lupus erythematosus with certain types of military service. This ensures that claimants and relevant authorities have a clear framework for assessing eligibility for benefits and compensation. The Instrument was finalised after an investigation into the medical-scientific evidence concerning discoid lupus erythematosus, and it was determined that the legislation is compatible with human rights as outlined in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011. The Repatriation Medical Authority consulted widely with relevant organisations and individuals before finalising the Instrument, ensuring that it promotes human rights, including the right to social security and the right to an adequate standard of living for veterans and their dependents.

Scope and Application

The Repatriation Medical Authority Instrument No. 126 of 2015 outlines the Statement of Principles concerning discoid lupus erythematosus (Reasonable Hypothesis) as determined under the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. This Statement of Principles is designed to establish the minimum factors that must exist to raise a reasonable hypothesis connecting discoid lupus erythematosus, or death from it, to particular kinds of service, including operational, peacekeeping, hazardous, British nuclear test defence, warlike, and non-warlike service. These principles are applied in the determination of claims under both the VEA and the MRCA, and any claims related to discoid lupus erythematosus or death from it lodged on or after 1 June 1994 for the VEA and 1 July 2004 for the MRCA must uphold these principles to be accepted by the relevant authorities. The instrument finalises the investigation concerning discoid lupus erythematosus, ensuring that the determination of such claims is based on sound medical-scientific evidence, thereby facilitating both the assessment and review processes. This legislative instrument is also compliant with human rights as it does not derogate from and promotes various human rights, including the right to social security and the right to an adequate standard of living.

Key Provisions

The Statement of Principles concerning discoid lupus erythematosus (Reasonable Hypothesis) (No. 126 of 2015), determined under the Veterans’ Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA), outlines the specific factors that must be present to establish a link between the condition and certain types of service (section 4). This Statement of Principles is applicable to claims made under the VEA and the MRCA, and it specifies the minimum conditions that must be related to operational, peacekeeping, hazardous, and British nuclear test defence services under the VEA, and warlike and non-warlike services under the MRCA (section 4). Claims for pension or compensation related to discoid lupus erythematosus or death from this condition cannot be accepted if lodged after 1 June 1994 under the VEA or 1 July 2004 under the MRCA unless the Statement of Principles supports the claim (subsection 120A(3) of the VEA and subsection 338(3) of the MRCA). This determination follows an investigation into the medical-scientific evidence regarding the condition, which was publicly notified in the Government Notices Gazette on 4 November 2014 (section 6). The Authority engaged in extensive consultation with relevant stakeholders, including veterans' organisations and experts in the field, before making this determination. The obligations imposed by this Statement of Principles require claimants to demonstrate that the specified factors are related to the service they performed, which must be one of the types of service outlined in the Statement (section 4). The Repatriation Commission, Military Rehabilitation and Compensation Commission, Veterans’ Review Board, and the Administrative Appeals Tribunal must consider this Statement of Principles when assessing claims, ensuring that the claims meet the minimum conditions set out in the document. This requirement ensures that the claims are evaluated based on sound medical-scientific evidence, facilitating a fair and transparent process for claimants. Failure to comply with the provisions of this Statement of Principles can result in the rejection of claims for pension or compensation related to discoid lupus erythematosus or death from this condition. Claimants whose claims do not meet the specified conditions will not be eligible for benefits under the VEA or the MRCA. This strict adherence to the Statement of Principles aims to ensure that benefits are awarded based on credible medical-scientific evidence, maintaining the integrity of the compensation system. There are no explicit penalties stated in the Explanatory Statement for non-compliance, but the consequence is the denial of claims that do not meet the specified conditions.

Legal classification tags

Area of Law
Veterans' Law
Human Rights Law
Instrument
Statutory Instrument
Concepts
Definitions & Interpretation
Reporting & Disclosure Obligations
Rights & Protections
Consultation Requirements

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.